×
About 9,015 results

ALLMedicine™ Aphasia Center

Research & Reviews  3,110 results

Distinctions and blurred boundaries between qualitative approaches and public and patie...
https://doi.org/10.1080/17549507.2022.2075465
International Journal of Speech-language Pathology; Mc Menamin R, Isaksen J et. al.

Jun 29th, 2022 - Purpose: International health and social care policy increasingly draws on stakeholder experiences and opinions. The distinctions between various approaches to researching "insider" perspectives are contentious. This article explores features (e.g...

The adaptation of the Object and Action Naming Battery into Moroccan Arabic: Norms for ...
https://doi.org/10.1080/23279095.2022.2089041
Applied Neuropsychology. Adult; Rami Y, Diouny S et. al.

Jun 29th, 2022 - The ability to name pictures has been investigated widely in healthy people and clinical populations. The Object and Action Naming Battery (OANB) is widely used for psycholinguistic research, aphasia research, and clinical practice. Normative data...

No evidence of impediment by three common classes of prescription drugs to post-stroke ...
https://doi.org/10.1371/journal.pone.0270135
PloS One; Stockbridge MD, Keser Z et. al.

Jun 25th, 2022 - A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a less robust recovery. Here we examine whether post-stro...

Right temporal lobe and socioemotional semantics: semantic behavioural variant frontote...
https://doi.org/10.1093/brain/awac217
Brain : a Journal of Neurology; Younes K, Borghesani V et. al.

Jun 23rd, 2022 - Focal anterior temporal lobe (ATL) degeneration often preferentially affects the left or right hemisphere. While patients with left-predominant ATL (lATL) atrophy show severe anomia and verbal semantic deficits and meet criteria for semantic varia...

Infective Endocarditis
https://emedicine.medscape.com/article/216650-overview

Jun 22nd, 2022 - Practice Essentials Infective endocarditis (IE) is an infection of the endocardial surfaces of the heart—usually of 1 or more cardiac valves; to a lesser degree the mural endocardium, or a septal defect. IE may lead to severe valvular insufficienc...

see more →

Guidelines  1 results

Return to Work for People With Aphasia.
https://doi.org/10.1016/j.apmr.2021.12.020
Archives of Physical Medicine and Rehabilitation; Gilmore N, Fraas M et. al.

Apr 9th, 2022 - Return to Work for People With Aphasia.|2022|Gilmore N,Fraas M,Hinckley J,|

see more →

Drugs  18 results see all →

Clinicaltrials.gov  344 results

tDCS Intervention in Primary Progressive Aphasia
https://clinicaltrials.gov/ct2/show/NCT02606422

Jun 22nd, 2022 - A. Evaluation Tasks Language Tasks: Participants will be administered baseline language and cognitive tasks, including 1 or more of the following, depending on their residual language and cognitive skills: a) writing to dictation b) oral spelling ...

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
https://clinicaltrials.gov/ct2/show/NCT03887481

Jun 22nd, 2022 - This proposal will extend the investigators' previous award, that provided the first evidence from a clinical trial (double-blind, sham-controlled, crossover), on the beneficial effects of transcranial direct current stimulation (tDCS) over the le...

The Intensive Comprehensive Aphasia Program (ICAP)
https://clinicaltrials.gov/ct2/show/NCT03514186

Jun 21st, 2022 - Recent research has emphasized the need for intensive aphasia treatment in order to make the long-term neuroplastic changes associated with recovery and rehabilitation following a stroke. Furthermore, studies have indicated that intensive aphasia ...

Timing of Transcranial Direct Current Stimulation (tDCS) Combined With Speech and Language Therapy (SLT)
https://clinicaltrials.gov/ct2/show/NCT03773406

Jun 21st, 2022 - tDCS Implementation: 2mA of direct current for 20 minutes will be delivered using a constant current stimulator via two electrodes in saline soaked sponges. To stimulate the left angular gyrus, a cathodal electrode inside a saline soaked sponge (5...

Improving Electronic Written Communication in Aphasia
https://clinicaltrials.gov/ct2/show/NCT03773419

Jun 21st, 2022 - An acquired impairment in writing, also known as agraphia, is a characteristic symptom of aphasia, i.e., a language disorder resulting from damage to the language centers of the brain. Written communication via text and instant messaging, electron...

see more →

News  121 results

Malpractice Case: How Diagnosis and Handoff Mishaps Led to Patient's Severe Stroke Outcome
https://www.medscape.com/viewarticle/975740

Jun 22nd, 2022 - It's well understood that physicians have limited time to treat patients with stroke before the disease progresses and outcomes can worsen. This case illustrates how differing opinions by remote and in-person physicians — followed by system breakd...

Severe ipsilateral headache
https://www.mdedge.com/migraine-challenge-center/article/255411/migraine/severe-ipsilateral-headache

Jun 14th, 2022 - On the basis of the patient's presentation, family history, and personal history of headache, she seems to be presenting with hemiplegic migraine, an uncommon migraine subtype characterized by recurrent headaches associated with temporary unilater.

A Biomarker Linked to Primary Progressive Aphasia Severity
https://www.medscape.com/viewarticle/974963

Jun 2nd, 2022 - The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways High tCr and low glutamate+glutamine (Glx) metabolite levels in the left inferior frontal gyrus (IFG) correlate with gre...

Uncertain Results for Tenecteplase in 'Wake-up' Stroke
https://www.medscape.com/viewarticle/973876

May 12th, 2022 - In patients with "wake-up" stroke selected by noncontrast CT, treatment with tenecteplase did not significantly improve functional outcome at 90 days in the TWIST trial. Although tenecteplase treatment was associated with a higher proportion of pa...

FDA Approves Axicabtagene Ciloleucel for Second-Line LBCL
https://www.onclive.com/view/fda-approves-axicabtagene-ciloleucel-for-second-line-lbcl

Apr 28th, 2022 - The FDA has approved axicabtagene ciloleucel (axi-cel; Yescarta) for the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.1 Th...

see more →

Patient Education  12 results see all →